版本:
中国

BRIEF-Agenus commences phase 1 trial with neoantigen cancer vaccine autosynvax

April 5 Agenus Inc

* Agenus commences phase 1 trial with neoantigen cancer vaccine autosynvax

* Agenus Inc - preclinical data presented at AACR 2017 annual meeting show ASV to be active and synergistic with checkpoint blockade Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐